©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 28, 2012; 18(36): 5072-5077
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5072
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5072
Table 3 Two-year disease-free survival according to the Kaplan-Meier method
| Variable | No. of patients | Two-year DFS (%) | Log-rank P |
| Age (yr) | 0.29 | ||
| ≥ 60 | 81 | 90.1 | |
| < 60 | 82 | 85.4 | |
| Sex | 0.08 | ||
| Male | 98 | 83.7 | |
| Female | 65 | 93.8 | |
| TNM stage | < 0.01 | ||
| I | 23 | 100 | |
| II | 67 | 98.5 | |
| III | 64 | 78.1 | |
| IV | 9 | 44.4 | |
| SUVmax | 0.53 | ||
| ≥ 8.6 | 83 | 86.7 | |
| < 8.6 | 80 | 88.8 | |
| CEA (ng/mL) | < 0.01 | ||
| > 5 | 36 | 72.2 | |
| ≤ 5 | 123 | 93.5 |
- Citation: Lee JE, Kim SW, Kim JS, Choi KY, Kang WK, Oh ST, Yoo IR, Kim SH. Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer. World J Gastroenterol 2012; 18(36): 5072-5077
- URL: https://www.wjgnet.com/1007-9327/full/v18/i36/5072.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i36.5072